Industry Webcast
Collaborative Care to Improve the Outcomes of Patients with Cardio-Renal-Metabolic DisordersIndustry Webcast Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC; Not for CME/CE Credit
Type 2 diabetes (T2D) is one of the most prevalent metabolic conditions of our time, requiring multifocal care and management. Join us as we explore the interconnectivity of the cardiovascular, renal, and metabolic (CRM) systems and the impact that comorbidities in these systems can have on patients with T2D. We will discuss guideline-directed care for patients with T2D and the need for a collaborative care approach to optimize outcomes for patients with disorders of the CRM systems.
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 4/17/2025
Expiration Date: 4/17/2025
Topics
Faculty
Faculty
Supporters and Partners
Industry Sponsor
Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.